Imaging Advances in Light Chain Amyloidosis

Area of Science:

• Cardiology
• Oncology
• Radiology

Background:

• Light chain (AL) amyloidosis is a systemic plasma cell disorder.
• Cardiac involvement significantly impacts prognosis and survival outcomes.
• Heterogeneity in disease necessitates early diagnosis, risk stratification, and tailored therapy.

Purpose of the Study:

• To review recent advances in multimodality imaging for AL amyloidosis.
• To highlight the shift towards quantitative tissue characterization in imaging.
• To emphasize the role of imaging in guiding personalized patient management.

Main Methods:

• Review of current literature on echocardiography, MRI, and nuclear medicine imaging in AL amyloidosis.
• Synthesis of data on quantitative and multiparametric imaging techniques.
• Focus on non-invasive assessment of cardiac involvement.

Main Results:

• Multimodality imaging is crucial for non-invasive evaluation of AL amyloidosis.
• Imaging modalities provide insights beyond anatomical assessment.
• Quantitative tissue characterization is advancing patient management.

Conclusions:

• Advanced imaging is indispensable for diagnosing and managing AL amyloidosis.
• Personalized treatment strategies are increasingly guided by imaging data.
• Multimodality imaging enhances risk stratification and response assessment.